Orchard Therapeutics Plc ADR (ORTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,182 | -151,979 | -118,359 | -98,069 | -50,569 |
| Depreciation Amortization | 392 | 361 | 5 | -768 | -1,209 |
| Income taxes - deferred | 781 | -2,257 | -1,458 | N/A | N/A |
| Accounts receivable | 887 | 582 | -1,750 | 642 | 670 |
| Accounts payable and accrued liabilities | -8,905 | -12,278 | N/A | -9,644 | N/A |
| Other Working Capital | -13,345 | -3,628 | -23,318 | -18,412 | -14,140 |
| Other Operating Activity | 16,130 | 42,925 | 30,440 | 38,239 | 15,346 |
| Operating Cash Flow | $-39,242 | $-126,274 | $-114,440 | $-88,012 | $-49,902 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -83,187 | 168,171 | 145,335 | 118,646 | 68,143 |
| PPE Investments | -339 | -2,668 | -2,551 | -2,484 | -1,329 |
| Other Investing Activity | 0 | -8,124 | -8,124 | -8,124 | -10,000 |
| Investing Cash Flow | $-83,526 | $157,379 | $134,660 | $108,038 | $56,814 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 150,000 | N/A | N/A | 2,582 | 1,438 |
| Other Financing Activity | -3,566 | 3,936 | 2,831 | 0 | 0 |
| Financing Cash Flow | $146,434 | $3,936 | $2,831 | $2,582 | $1,438 |
| Exchange Rate Effect | 82 | 1,043 | -941 | -485 | -303 |
| Beginning Cash Position | 59,401 | 23,317 | 23,317 | 23,317 | 23,317 |
| End Cash Position | 83,149 | 59,401 | 45,427 | 45,440 | 31,364 |
| Net Cash Flow | $23,748 | $36,084 | $22,110 | $22,123 | $8,047 |
| Free Cash Flow | |||||
| Operating Cash Flow | -39,242 | -126,274 | -114,440 | -88,012 | -49,902 |
| Capital Expenditure | -339 | -2,668 | -2,551 | -2,484 | -1,329 |
| Free Cash Flow | -39,581 | -128,942 | -116,991 | -90,496 | -51,231 |